{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:56:36Z","timestamp":1782845796225,"version":"3.54.5"},"reference-count":20,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Bioinform Biotech"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Sensitivity\u2014expressed as percent positive agreement (PPA) with a reference assay\u2014is a primary metric for evaluating lateral-flow antigen tests (ATs), typically benchmarked against a quantitative reverse transcription polymerase chain reaction (qRT-PCR). In SARS-CoV-2 diagnostics, ATs detect nucleocapsid protein, whereas qRT-PCR detects viral RNA copy numbers. Since observed PPA depends on the underlying viral load distribution (proxied by the number of cycle thresholds [Cts], which is inversely related to load), study-specific sampling can bias sensitivity estimates. Cohort differences\u2014such as enrichment for high- or low-Ct specimens\u2014therefore complicate cross-test comparisons, and real-world datasets often deviate from regulatory guidance to sample across the full concentration range. Although logistic models relating test positivity to Ct are well described, they are seldom used to reweight results to a standardized reference viral load distribution. As a result, reported sensitivities remain difficult to compare across studies, limiting both accuracy and generalizability.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The aim of this study was to develop and validate a statistical methodology that estimates the sensitivity of ATs by recalibrating clinical performance data\u2014originally obtained from uncontrolled viral load distributions\u2014against a standardized reference distribution of target concentrations, thereby enabling more accurate and comparable assessments of diagnostic test performance.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n AT sensitivity is estimated by modeling the PPA as a function of qRT-PCR Ct values (PPA function) using logistic regression on paired test results. Raw sensitivity is the proportion of AT positives among PCR-positive samples. Adjusted sensitivity is calculated by applying the PPA function to a reference Ct distribution, correcting for viral load variability. This enables standardized comparisons across tests. The method was validated using clinical data from a community study in Chelsea, Massachusetts, demonstrating its effectiveness in reducing sampling bias.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Over a 2-year period, paired ATs and qRT-PCR\u2013positive samples were collected from 4 suppliers: A (n=211), B (n=156), C (n=85), and D (n=43). Ct value distributions varied substantially, with suppliers A and D showing lower Ct (high viral load) values in the samples, and supplier C skewed toward higher Ct values (low viral load). These differences led to inconsistent raw sensitivity estimates. To correct for this, we used logistic regression to model the PPA as a function of Cts and applied these models to a standardized reference Ct distribution. This adjustment reduced bias and enabled more accurate comparisons of test performance across suppliers.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n We present a distribution-aware framework that models PPA as a logistic function of Ct and reweights results to a standardized reference Ct distribution to produce bias-corrected sensitivity estimates. This yields fairer, more consistent comparisons across AT suppliers and studies, strengthens quality control, and supports regulatory review. Collectively, our results provide a robust basis for recalibrating reported sensitivities and underscore the importance of distribution-aware evaluation in diagnostic test assessment.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/68476","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:21:40Z","timestamp":1760984500000},"page":"e68476-e68476","source":"Crossref","is-referenced-by-count":0,"title":["Estimating Antigen Test Sensitivity via Target Distribution Balancing: Development and Validation Study"],"prefix":"10.2196","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0206-2427","authenticated-orcid":false,"given":"Miguel","family":"Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6336-1618","authenticated-orcid":false,"given":"Adriana","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0520-1069","authenticated-orcid":false,"given":"Raul","family":"Colmenares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1407-5904","authenticated-orcid":false,"given":"Jose","family":"Arocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0452-4146","authenticated-orcid":false,"given":"Sina","family":"Hoche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9233-5806","authenticated-orcid":false,"given":"Auris","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4375-0225","authenticated-orcid":false,"given":"Daniela","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9489-8506","authenticated-orcid":false,"given":"Dawlyn","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4638-144X","authenticated-orcid":false,"given":"Lindsey","family":"Rudtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4232-3268","authenticated-orcid":false,"given":"Nol","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1352-5888","authenticated-orcid":false,"given":"Irene","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"issue":"22","key":"R1","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.3748\/wjg.v20.i22.6701","article-title":"Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatment","volume":"20","author":"Tillmann","journal-title":"World J Gastroenterol"},{"issue":"12","key":"R2","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1128\/JCM.01816-15","article-title":"Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: systematic review and meta-analysis","volume":"53","author":"Chartrand","journal-title":"J Clin Microbiol"},{"issue":"1","key":"R3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000360","article-title":"Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses","volume":"3","author":"Ty Hang","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"R4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-407","article-title":"Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies","volume":"13","author":"Lawn","journal-title":"BMC Infect Dis"},{"issue":"10","key":"R5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103372","article-title":"Rapid antibody-based COVID-19 mass surveillance: relevance, challenges, and prospects in a pandemic and post-pandemic world","volume":"9","author":"Augustine","journal-title":"J Clin Med"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100924","article-title":"COVID-19: rapid antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation of sensitivity and specificity for mass-testing","volume":"36","author":"Peto","journal-title":"EClinicalMedicine"},{"issue":"9","key":"R7","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1016\/S2666-5247(21)00143-9","article-title":"Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study","volume":"2","author":"Pickering","journal-title":"Lancet Microbe"},{"issue":"5","key":"R8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JCM.00083-21","article-title":"Performance and implementation evaluation of the Abbott BinaxNOW rapid antigen test in a high-throughput drive-through community testing site in Massachusetts","volume":"59","author":"Pollock","journal-title":"J Clin Microbiol"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103455","article-title":"Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR","volume":"69","author":"Wagenh\u00e4user","journal-title":"EBioMedicine"},{"issue":"32","key":"R10","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.32.2001483","article-title":"Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020","volume":"25","author":"Singanayagam","journal-title":"Euro Surveill"},{"issue":"6","key":"R11","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11061091","article-title":"Viral dynamics and real-time RT-PCR Ct values correlation with disease severity in COVID-19","volume":"11","author":"Rabaan","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"R12","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1093\/ije\/dyaa090","article-title":"Common misconceptions about validation studies","volume":"49","author":"Fox","journal-title":"Int J Epidemiol"},{"issue":"1","key":"R13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2307\/2333860","article-title":"Estimation of the probability of an event as a function of several independent variables","volume":"54","author":"Walker","journal-title":"Biometrika"},{"issue":"7","key":"R14","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1016\/S2666-5247(21)00056-2","article-title":"Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study","volume":"2","author":"Corman","journal-title":"Lancet Microbe"},{"key":"R15","unstructured":"Community study to evaluate the performance of COVID-19 frequent antigen testing at home through digital health reporting. Reagan-Udall Foundation. 2022. URL: https:\/\/reaganudall.org\/clinical-trial\/evaluation-home-use-covid-19-frequent-antigen-testing-and-data-reporting [Accessed 09-10-2025]"},{"issue":"4","key":"R16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","journal-title":"Biometrika"},{"key":"R17","unstructured":"Practical applications of real-world evidence to enable regulatory submissions. Reagan-Udall Foundation. URL: https:\/\/reaganudall.org\/sites\/default\/files\/2023-09\/PIVD%20Commentary%20FINAL3419899_%20bf%20092123.pdf [Accessed 10-10-2025]"},{"issue":"13","key":"R18","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1200\/JCO.21.02419","article-title":"Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the National COVID Cohort Collaborative","volume":"40","author":"Song","journal-title":"J Clin Oncol"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33460-0","article-title":"Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants","volume":"13","author":"Del Vecchio","journal-title":"Nat Commun"},{"key":"R20","unstructured":"IDX20. URL: https:\/\/www.idx20.us\/ [Accessed 10-10-2025"}],"container-title":["JMIR Bioinformatics and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bioinform.jmir.org\/2025\/1\/e68476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:55:18Z","timestamp":1782842118000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioinform.jmir.org\/2025\/1\/e68476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2196\/68476","relation":{},"ISSN":["2563-3570"],"issn-type":[{"value":"2563-3570","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"article-number":"v6i22e68476"}}